2024

18th WFH Workshop on New Technology & Gene Therapy
7-8 Nov 2024 | Montreal
Talk: FVIII intron 1 inversion editing (Frank Buchholz)
—

ESGCT 2024
22-25 Oct 2024 | Rome
Talk: Engineering Designer-Recombinases for therapeutic genome editing (Frank Buchholz)
—

FASEB 2024 Genome Engineering Conference
16-20 Jun 2024 | Rome
Talk: Engineering Designer-Recombinases for Therapeutic Genome Editing (Frank Buchholz)
—

COST CA21113 Conference and Meeting (GenE-HumDi)
8-10 Apr 2024 | Limassol
Talk: Persistent epigenome editing and mechanisms (Frank Buchholz)
—

DG-GT 30th Annual Meeting
6-8 Mar 2024 | Munich
Talk: Engineering Designer-Recombinases for therapeutic genome editing (Frank Buchholz)

2023

Leipzig Immune Oncology (LION) Conference
8-9 Nov 2023 | Leipzig
Keynote: Genome editing in cancer research (Frank Buchholz)
—

Exhibition “On Genes and Human Beings” at Deutsches Hygiene-Museum Dresden
16 Mar 2023 | Deutsches Hygiene-Museum Dresden
Panel discussion and podcast “You Ask We Explain” (Frank Buchholz)

2022

FASEB 2022 Genome Engineering conference
26-30 Jun 2022 | Lisbon
Talk: Correction of a disease causing genomic inversion with designer recombinases (Frank Buchholz)
—

DG-GT Symposium “Making Gene Therapy a Clinical Reality”
23-25 Mar 2022 | Hanover
Talk: Evolving molecular scissors for antiviral gene therapy (Frank Buchholz)

2021

ESGCT 2021
19-22 Oct 2021 | Online
Talk: Development of Designer-Recombinases to target retroviral infections (Frank Buchholz)
—

Erasmus Hematology Lectures
2021 | Rotterdam
Talk: A Designer-Recombinase Platform for Therapeutic Genome Editing (Frank Buchholz)